|
|
|
|
| 專題 |
最後回覆 |
暱稱 |
內容 |
| 中國神威藥業集團有限公司 |
2013-04-07T08:32 |
財經茄呢啡 |
神威藥業（2877）主要從事研發及產銷現代化中藥，近年主打產品被列入基本藥物目錄，而且具充裕現金進行併購，加上注射液業務表現理想，去年下半年銷情較上半年改善，預料按年能有雙位數增長。 |
|
|
|
|
We've noticed you're using an ad blocker
We spend millions of dollars each year so you can access, for FREE, the highest quality real-time quotes and charts. This is made possible only thanks to the advertising on our site.
To continue using 88iv.com, please allow this domain on your ad blocker.
We are thanksful for your decisive action.
This notice will be shown again every hour.
Close This Window